CareDx shares have plunged on a proposed Medicare coverage change, but management expects no impact on test usage and maintains strong financial guidance. Despite legal victories and double-digit ...

CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

In 1997, avian influenza virus (H5N1) caused severe human disease in Hong Kong. One of 9 infected children and 5 of 9 infected adults died. Investigators hypothesized that this virus is lethal because ...

CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ...

CareDx (CDNA) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.03 per share a year ago. These figures are ...

In addition to the Instinct MI325X AI Accelerator, AMD also updated its AMD Instinct roadmap and previewed the upcoming Instinct MI355X AI Accelerator at its Advance AI event held earlier. Based on ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...

AMD’s new UDNA strategy is all about AI, and it’s hard to blame the company. AMD’s new UDNA strategy is all about AI, and it’s hard to blame the company. is a senior editor and founding member of The ...

Ever since it bought GPU firm ATI Technologies in 2006, AMD has experimented with all kinds of graphics architectures. Its current approach, one for PC clients and the other for data and AI servers, ...